Literature DB >> 25725428

Co-transplantation of human fetal thymus, bone and CD34(+) cells into young adult immunodeficient NOD/SCID IL2Rγ(null) mice optimizes humanized mice that mount adaptive antibody responses.

Yun Shin Chung1, Jin Kyung Son1, Bongkum Choi1, Sung-Yeon Joo2, Yong-Soo Lee1, Jae Berm Park3, Hana Moon4, Tae Jin Kim4, Se Ho Kim5, Seokmann Hong6, Jun Chang7, Myung-Soo Kang8, Sung Joo Kim9.   

Abstract

Both the thymus (T) and bone (B) are necessary hematopoietic niches in adult humans. We previously showed that co-transplantation of human fetal T and B tissues into neonatal immunodeficient NOD/SCID IL2Rγ(null) (NSG, N) mice facilitated hematopoiesis. However, transplantation into neonatal mice resulted in high frequency of early death, making it unrealistic for repetitive experiments. In this study, young adult N mice were pre-engrafted with T and B, T alone, B alone or no tissues. The animals were irradiated and injected with autologous fetal liver (FL)-derived CD34(+) cells (34). The resultant mice were TB34N, T34N, B34N and 34N, respectively, and challenged with T cell dependent antigens (Ags). The humanized TB34N mice showed best performance of these mouse models in many aspects resembling the adult human Ag-experienced spleen. The TB34N mice exhibited better hematopoietic reconstitution; balanced development of T- and B-cell, and common progenitor cells; follicular lymphoid structures with a functional germinal center (GC) enriched with follicular dendritic cells (FDCs) and plasma cells (PCs); secretion of hIgG in the sera in response to Ags at comparable levels to those of human; derivations of hIgG mAb-secreting hybridoma clones. Collectively, the humanized TB34N mice could develop an adaptive immunity that was capable of producing Ag-specific hIgG at a significant level via class switching. This unprecedented TB34N platform in humanized mice would be useful in dissecting human immunity, for generating human Abs and clinical applications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; CD34(+) cells; Hematopoiesis; Humanized mice; Thymus; Young adult NOD/SCID IL2Rγ(null)

Mesh:

Substances:

Year:  2015        PMID: 25725428     DOI: 10.1016/j.clim.2015.02.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  6 in total

Review 1.  Vaccines licensed and in clinical trials for the prevention of dengue.

Authors:  J Torresi; G Ebert; M Pellegrini
Journal:  Hum Vaccin Immunother       Date:  2017-02-14       Impact factor: 3.452

2.  Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer.

Authors:  John J Morton; Stephen B Keysar; Loni Perrenoud; Tugs-Saikhan Chimed; Julie Reisinger; Brian Jackson; Phuong N Le; Cera Nieto; Karina Gomez; Bettina Miller; Dexiang Gao; Hilary Somerset; Xiao-Jing Wang; Antonio Jimeno
Journal:  Mol Carcinog       Date:  2018-09-03       Impact factor: 4.784

3.  The Establishment of an In Vivo HIV-1 Infection Model in Humanized B-NSG Mice.

Authors:  Tian-Jiao Fan; Li Sun; Xian-Guang Yang; Xia Jin; Wei-Wei Sun; Jian-Hua Wang
Journal:  Virol Sin       Date:  2019-12-21       Impact factor: 4.327

4.  Human Cytomegalovirus Induces Cellular and Humoral Virus-specific Immune Responses in Humanized BLT Mice.

Authors:  Lindsey B Crawford; Rebecca Tempel; Daniel N Streblow; Craig Kreklywich; Patricia Smith; Louis J Picker; Jay A Nelson; Patrizia Caposio
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

5.  Creation of an immunodeficient HLA-transgenic mouse (HUMAMICE) and functional validation of human immunity after transfer of HLA-matched human cells.

Authors:  Yang Zeng; Bingrun Liu; Marie-Thérèse Rubio; Xinyue Wang; David M Ojcius; Ruoping Tang; Antoine Durrbach; Zhitao Ru; Yusen Zhou; Yu-Chun Lone
Journal:  PLoS One       Date:  2017-04-11       Impact factor: 3.240

Review 6.  A Hitchhiker's guide to humanized mice: new pathways to studying viral infections.

Authors:  Jessica Katy Skelton; Ana Maria Ortega-Prieto; Marcus Dorner
Journal:  Immunology       Date:  2018-03-09       Impact factor: 7.397

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.